These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21572307)

  • 21. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
    AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.
    ; Lodi S; del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Olson A; van Sighem A; Reiss P; Sabin C; Jose S; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Vourli G; Antoniadou A; Dabis F; Vandenhede MA; Costagliola D; Abgrall S; Hernán MA
    AIDS; 2014 Oct; 28(16):2461-73. PubMed ID: 25265230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.
    Chao C; Xu L; Abrams DI; Towner WJ; Horberg MA; Leyden WA; Silverberg MJ
    AIDS; 2011 Sep; 25(14):1771-7. PubMed ID: 21681055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
    Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
    Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
    Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
    AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune reconstitution inflammatory syndrome: incidence and implications for mortality.
    Novak RM; Richardson JT; Buchacz K; Chmiel JS; Durham MD; Palella FJ; Wendrow A; Wood K; Young B; Brooks JT;
    AIDS; 2012 Mar; 26(6):721-30. PubMed ID: 22233655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J; Bossi P
    Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology.
    McCombe JA; Auer RN; Maingat FG; Houston S; Gill MJ; Power C
    Neurology; 2009 Mar; 72(9):835-41. PubMed ID: 19255411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
    Ogoina D; Adekunle V; Obiako R; Umar A; Akolawole M; Ovosi J
    Pan Afr Med J; 2011; 9():38. PubMed ID: 22355437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIDS-associated malignancies.
    Akanmu AS
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():57-70. PubMed ID: 18050776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
    Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
    AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
    Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
    AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Fatal Case of Kaposi Sarcoma Immune Reconstitution Syndrome (KS-IRIS) Complicated by Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) or Multicentric Castleman Disease (MCD): A Case Report and Review.
    Dumic I; Radovanovic M; Igandan O; Savic I; Nordstrom CW; Jevtic D; Subramanian A; Ramanan P
    Am J Case Rep; 2020 Dec; 21():e926433. PubMed ID: 33268763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma.
    Kowalkowski MA; Mims MP; Amiran ES; Lulla P; Chiao EY
    PLoS One; 2013; 8(10):e77409. PubMed ID: 24098586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
    del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
    Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.